다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Molecular medicine reports, v.17 no.2, 2018년, pp.2456 - 2464
Wu, Guixia (Department of Physiology, Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China) , Li, Jing (Department of Physiology, Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China) , Yue, Jinqiao (Department of Medical Examination, Changji Vocational and Technical College, Changji, Xinjiang 830000, P.R. China) , Zhang, Shuying (Department of Gynaecology and Obstetrics, The 474th Hospital of People's Liberation Army of China, Urumqi, Xinjiang 830011, P.R. China) , Yunusi, Kurexi (Department of Biochemistry, Xinjiang Medical University, Urumqi, Xinjiang 830011, P.R. China)
AI-Helper
Luteolin is a falconoid compound that is present in various types of plants and possesses remarkable potential as a chemopreventive agent. However, the poor aqueous solubility of luteolin limits its clinical application. In the present study, an approach towards chemoprevention was explored using li...
1 Yang C Liu HZ Fu ZX Lu WD Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma BMC Biotechnol 11 21 2011 10.1186/1472-6750-11-21 3064655 --> 21401960
2 Nobili S Checcacci D Filippelli F Del Buono S Mazzocchi V Mazzei T Mini E Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy J Chemother 20 622 631 2008 10.1179/joc.2008.20.5.622 19028627
3 Chen AY Chen YC A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention Food Chem 138 2099 2107 2013 10.1016/j.foodchem.2012.11.139 23497863
4 Majumdar D Jung KH Zhang H Nannapaneni S Wang X Amin AR Chen Z Chen ZG Shin DM Luteolin nanoparticle in chemoprevention: In vitro and in vivo anticancer activity Cancer Prev Res (Phila) 7 65 73 2014 10.1158/1940-6207.CAPR-13-0230 3888883 --> 24403290
5 Sporn MB Dunlop NM Newton DL Smith JM Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids) Fed Proc 35 1332 1338 1976 770206
6 Madhunapantula SV Robertson GP Chemoprevention of melanoma Adv Pharmacol 65 361 398 2012 10.1016/B978-0-12-397927-8.00012-9 3628531 --> 22959032
7 Mann CD Neal CP Garcea G Manson MM Dennison AR Berry DP Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis Eur J Cancer Prev 18 13 25 2009 10.1097/CEJ.0b013e3282f0c090 19077560
8 Khor TO Yu S Kong AN Dietary cancer chemopreventive agents-targeting inflammation and Nrf2 signaling pathway Planta Med 74 1540 1547 2008 10.1055/s-0028-1088303 18937168
9 Kaur M Singh RP Gu M Agarwal R Agarwal C Grape seed extract inhibits in vitro and in vivo growth of human colorectal carcinoma cells Clin Cancer Res 12 6194 6202 2006 10.1158/1078-0432.CCR-06-1465 17062697
10 Kaur M Velmurugan B Tyagi A Agarwal C Singh RP Agarwal R Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling Neoplasia 12 415 424 2010 10.1593/neo.10188 2864479 --> 20454513
11 Benbrook DM Guruswamy S Wang Y Sun Z Mohammed A Zhang Y Li Q Rao CV Chemoprevention of colon and small intestinal tumorigenesis in APC(min/+) mice by SHetA2 (NSC721689) without toxicity Cancer Prev Res (Phila) 6 908 916 2013 10.1158/1940-6207.CAPR-13-0171 3769959 --> 23852423
12 Yang MY Wang CJ Chen NF Ho WH Lu FJ Tseng TH Luteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3 Chem Biol Interact 213 60 68 2014 10.1016/j.cbi.2014.02.002 24525192
13 Huang X Dai S Dai J Xiao Y Bai Y Chen B Zhou M Luteolin decreases invasiveness, deactivates STAT3 signaling and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase secretion of pancreatic cancer cells Onco Targets Ther 8 2989 3001 2015 10.2147/OTT.S91511 4621199 --> 26527884
14 Yan M Liu Z Yang H Li C Chen H Liu Y Zhao M Zhu Y Luteolin decreases the UVA-induced autophagy of human skin fibroblasts by scavenging ROS Mol Med Rep 14 1986 1992 2016 10.3892/mmr.2016.5517 4991762 --> 27430964
15 Lee HZ Yang WH Bao BY Lo PL Proteomic analysis reveals ATP-dependent steps and chaperones involvement in luteolin-induced lung cancer CH27 cell apoptosis Eur J Pharmacol 642 19 27 2010 10.1016/j.ejphar.2010.05.053 20553912
16 Ong CS Zhou J Ong CN Shen HM Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-cyclin D1 pathway Cancer Lett 298 167 175 2010 10.1016/j.canlet.2010.07.001 20655656
17 Chiu FL Lin JK Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts Prostate 68 61 71 2008 10.1002/pros.20690 18008333
18 Cai X Ye T Liu C Lu W Lu M Zhang J Wang M Cao P Luteolin induced G2 phase cell cycle arrest and apoptosis on non-small cell lung cancer cells Toxicol In Vitro 25 1385 1391 2011 10.1016/j.tiv.2011.05.009 21601631
19 Balyan R Kudugunti SK Hamad HA Yousef MS Moridani MY Bioactivation of luteolin by tyrosinase selectively inhibits glutathione S-transferase Chem Biol Interact 240 208 218 2015 10.1016/j.cbi.2015.08.011 26279214
20 Liu JF Ma Y Wang Y Du ZY Shen JK Peng HL Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress Phytother Res 25 588 596 2011 10.1002/ptr.3305 20925133
21 Abdel Hadi L Di Vito C Marfia G Ferraretto A Tringali C Viani P Riboni L Sphingosine kinase 2 and ceramide transport as key targets of the natural flavonoid luteolinto induce apoptosis in colon cancer cells PLoS One 10 e0143384 2015 10.1371/journal.pone.0143384 4651545 --> 26580959
22 Wölfle U Esser PR Simon-Haarhaus B Martin SF Lademann J Schempp CM UVB-induced DNA damage, generation of reactive oxygen species and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo Free Radic Biol Med 50 1081 1093 2011 10.1016/j.freeradbiomed.2011.01.027 21281711
23 Liu Y Wang L Zhao Y He M Zhang X Niu M Feng N Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin Int J Pharm 476 169 177 2014 10.1016/j.ijpharm.2014.09.052 25280882
24 Yuan Y Zhao Y Xin S Wu N Wen J Li S Chen L Wei Y Yang H Lin S A novel PEGylated liposome-encapsulated SANT75 suppresses tumor growth through inhibiting hedgehog signaling pathway PLoS One 8 e60266 2013 10.1371/journal.pone.0060266 3613365 --> 23560085
25 Fetterly GJ Grasela TH Sherman JW Dul JL Grahn A Lecomte D Fiedler-Kelly J Damjanov N Fishman M Kane MP Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxel Clin Cancer Res 14 5856 5863 2008 10.1158/1078-0432.CCR-08-1046 18794097
26 Gabizon A Catane R Uziely B Kaufman B Safra T Cohen R Martin F Huang A Barenholz Y Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res 54 987 992 1994 8313389
27 Guo L Fan L Ren J Pang Z Ren Y Li J Wen Z Qian Y Zhang L Ma H Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer Int J Nanomedicine 7 1449 1460 2012 3356168 --> 22619505
28 Li LT Jiang G Chen Q Zheng JN Ki67 is a promising molecular target in the diagnosis of cancer (Review) Mol Med Rep 11 1566 1572 2015 25384676
29 Koudelka S Turanek Knotigova P Masek J Prochazka L Lukac R Miller AD Neuzil J Turanek J Liposomal delivery systems for anti-cancer analogues of vitamin E J Control Release 207 59 69 2015 10.1016/j.jconrel.2015.04.003 25861728
30 Barenholz Y Doxil ® - the first FDA-approved nano-drug: Lessons learned J Control Release 160 117 134 2012 10.1016/j.jconrel.2012.03.020 22484195
31 Schiffelers RM Metselaar JM Fens MH Janssen AP Molema G Storm G Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice Neoplasia 7 118 127 2005 10.1593/neo.04340 1501128 --> 15802017
32 Gabizon A Martin F Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours Drugs 4 Suppl 54 S15 S21 1997 10.2165/00003495-199700544-00005
33 Harris L Batist G Belt R Rovira D Navari R Azarnia N Welles L Winer E TLC D-99 Study Group Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma Cancer 94 25 36 2002 10.1002/cncr.10201 11815957
34 Hioki A Wakasugi A Kawano K Hattori Y Maitani Y Development of an in vitro drug release assay of PEGylated liposome using bovine serum albumin and high temperature Biol Pharm Bull 33 1466 1470 2010 10.1248/bpb.33.1466 20823558
35 Deshpande PP Biswas S Torchilin VP Current trends in the use of liposomes for tumor targeting Nanomedicine (Lond) 8 1509 1528 2013 10.2217/nnm.13.118 23914966
36 Haley B Frenkel E Nanoparticles for drug delivery in cancer treatment Urol Oncol 26 57 64 2008 10.1016/j.urolonc.2007.03.015 18190833
37 Cukierman E Khan DR The benefits and challenges associated with the use of drug delivery systems in cancer therapy Biochem Pharmacol 80 762 770 2010 10.1016/j.bcp.2010.04.020 2897922 --> 20417189
38 Fan Y Liu J Wang D Song X Hu Y Zhang C Zhao X Nguyen TL The preparation optimization and immune effect of epimedium polysaccharide-propolis flavone liposome Carbohydr Polym 94 24 30 2013 10.1016/j.carbpol.2012.12.071 23544505
39 Zhu Y Wang M Zhang J Peng W Firempong CK Deng W Wang Q Wang S Shi F Yu J Improved oral bioavailability of capsaicin via liposomal nanoformulation: Preparation, in vitro drug release and pharmacokinetics in rats Arch Pharm Res 38 512 521 2014 10.1007/s12272-014-0481-7 25231341
42 Pratheeshkumar P Son YO Budhraja A Wang X Ding S Wang L Hitron A Lee JC Kim D Divya SP Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis PLoS One 7 e52279 2012 10.1371/journal.pone.0052279 3534088 --> 23300633
43 Matsumura Y Maeda H A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res 46 6387 6392 1986 2946403
44 Vasey PA Kaye SB Morrison R Twelves C Wilson P Duncan R Thomson AH Murray LS Hilditch TE Murray T Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer research campaign phase I/II committee Clin Cancer Res 5 83 94 1999 9918206
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.